GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Shiller PE Ratio

Biofarm (BSE:BIO) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Biofarm Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofarm Shiller PE Ratio Historical Data

The historical data trend for Biofarm's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofarm Shiller PE Ratio Chart

Biofarm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 15.35 10.24 -

Biofarm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.62 9.65 10.96 - -

Competitive Comparison of Biofarm's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofarm's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biofarm's Shiller PE Ratio falls into.



Biofarm Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biofarm's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Biofarm's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.021/131.7762*131.7762
=0.021

Current CPI (Mar. 2024) = 131.7762.

Biofarm Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.044 100.560 0.058
201409 0.061 100.428 0.080
201412 0.005 99.070 0.007
201503 0.014 99.621 0.019
201506 0.001 100.684 0.001
201509 0.006 100.392 0.008
201512 0.006 99.792 0.008
201603 0.007 100.470 0.009
201606 0.009 101.688 0.012
201609 0.009 101.861 0.012
201612 0.006 101.863 0.008
201703 0.009 102.862 0.012
201706 0.012 103.349 0.015
201709 0.009 104.136 0.011
201712 0.007 104.011 0.009
201803 0.012 105.290 0.015
201806 0.010 106.317 0.012
201809 0.014 106.507 0.017
201812 0.002 105.998 0.002
201903 0.016 107.251 0.020
201906 0.012 108.070 0.015
201909 0.012 108.329 0.015
201912 0.011 108.420 0.013
202003 0.019 108.902 0.023
202006 0.011 108.767 0.013
202009 0.016 109.815 0.019
202012 0.009 109.897 0.011
202103 0.023 111.754 0.027
202106 0.014 114.631 0.016
202109 0.019 115.734 0.022
202112 0.006 117.630 0.007
202203 0.027 121.301 0.029
202206 0.017 125.017 0.018
202209 0.022 125.227 0.023
202212 0.005 125.222 0.005
202303 0.032 127.348 0.033
202306 0.019 128.729 0.019
202309 0.020 129.860 0.020
202312 0.006 129.419 0.006
202403 0.021 131.776 0.021

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biofarm  (BSE:BIO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biofarm Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biofarm's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofarm (BSE:BIO) Business Description

Traded in Other Exchanges
N/A
Address
99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.

Biofarm (BSE:BIO) Headlines